Genomics Market  Study Report Based on Size, Shares, Opportunities, and Forecast to 2030

Increasing the number of government-sponsored genome projects will boost market revenue growth

The global genomics stock market size is expected to reach USD 129.34 Billion in 2030 and register a revenue CAGR of 19.0% over the forecast period, according to the latest report by Reports and Data. Increase in number of government-sponsored genome project is expected to boost the market revenue growth during forecast period. Demand for genomics stock is increasing further with introduction of novel equipment and increasing research investment. Government has taken initiatives to boost market's growth. For instance, as of January 2020, the Department of Biotechnology (DBT) announced the making of "Genome India Project" (GIP). Project's objective is to gather 10,000 genetic samples from Indian people in order to create a reference genome that can be used for research.

Development of personalized medication is driving market revenue growth and the ability to tailor medications to each patient's specific needs is quickly becoming one of the field's most attractive features. Clinicians can examine a person's genetic code in order to better determine what type of therapy is appropriate for them. It also has the power to improve the health and well-being of entire patient groups by enhancing therapy at a level higher than that of the individual.

A number of factors, such as high price of genomics stock kits and lack of skilled professionals, are expected to restrain the market's growth. Technological advancements have made it possible for the instruments in use to give an analysis; nonetheless, in most cases, readers provide the interpretation. 

Get a sample of the report @

Some Key Factors Contributing to the Global Pharma Healthcare Market Growth

Unprecedented revenue growth of the global pharma healthcare industry is attributed to factors such as rising prevalence of chronic and acute diseases worldwide, increasing geriatric population, rising awareness of health wellness among consumers, and growing demand for more advanced healthcare services. Increasing demand for advanced drugs and therapeutics, growing availability of next-generation diagnostics and treatment options – especially in developing countries like India and China – rise in RD activities and clinical trials in the pharmaceutical and biotechnology sectors, increasing public and private investments in healthcare research projects, and rising consumer expenditure on healthcare are among the other significant factors contributing to the industry revenue growth.

Some Key Highlights in the Report

    • PCR segment accounted for a significantly large revenue share in global genomics stock market in 2021 owing to increased demand for testing of COVID-19 virus. It offers several benefits such as faster results, shorter time to optimal therapy, improved treatment decisions, the ability to detect rare viruses, and other research applications. As a result, it finds use in the study of gene expression changes in cancers, bacteria, and other disease states.
    • Next Generation Sequencing (NGS) segment revenue is expected to register a steady growth rate during the forecast period as the approach is utilized to determine the nucleotide sequence of entire genomes or specific portions of Deoxyribonucleic Acid (DNA) or Ribonucleic Acid (RNA). NGS has transformed biological sciences by enabling laboratories to conduct a broad range of applications and research biological systems on a scale never achieved before.
    • Pharmaceutical firms are using accessible genetic data in customized treatment, which is expected to have a substantial influence on the market's growth. The costs of sequencing have decreased significantly, making whole-genome sequencing more appealing to biotechnology and pharmaceutical firms, increasing RD expenditure by pharmaceutical giants for discovering innovative gene treatments to fight cancer and immunological illnesses.
    • genomics stock market in Asia Pacific is expected to account for largest revenue share in the global market over the forecast period owing to increased demand from China for genetic sequencing and testing, as well as improvements in bioinformatics research in the region. To reach its objective of becoming a worldwide biotech leader, the People’s Republic of China (PRC) is significantly investing in the "biotech revolution" and has adopted national laws favoring the collecting of healthcare data, both at home and abroad. The PRC recognizes that collecting and analyzing huge genetic data sets from a variety of population aids in the development of novel medical discoveries and treatments with significant economic value, as well as the advancement of its artificial intelligence and precision medicine sectors.

Top Players in the Global Keyword Market:

Illumina, Inc, 10X genomics stock, GenScript, Intellia Therapeutics, Inc, CRISPR Therapeutics, Thermo Fisher Scientific, BGI genomics stock, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., and Myriad Genetics, Inc.

The coronavirus pandemic has had a drastic impact on the global healthcare industry, with rising cases of COVID-19 worldwide, substantially growing hospital admission and readmission rates, and rising demand for telehealth and telemedicine services for remote patient monitoring. Furthermore, rising focus on development of rapid COVID-19 diagnostics such as the RT-PCR test kits, increased government funding for vaccine development, stringent regulatory norms and protocols for COVID-19 safety, and increasing sales of COVID-19 safety equipment, such as N-95 masks, face shields, PPE kits, and hand sanitizers, have driven the global pharma healthcare industry revenue growth over the recent past.  

To know more about the report @ stock-market

Keyword Market Segmentation:

Product Services Outlook (Revenue, USD Billion; 2019 – 2030)

  • Consumables
  • System Software
  • Services

Technology Outlook (Revenue, USD Billion; 2019 – 2030)

  • Sequencing
  • PCR
  • Extraction and Purification of Nucleic Acid
  • Microarrays
  • Other Technologies

Application Outlook (Revenue, USD Billion; 2019 – 2030)

  • Drug Development
  • Diagnostics
  • Animal and Agriculture Research
  • Others

Global Keyword Market Report: Regional Segmentation

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East Africa
    • Saudi Arabia
    • U.A.E.
    • South Africa
    • Rest of MEA

Request customization of the report @

Frequently Asked Questions Answered in the Report:

  • What is the estimated revenue growth rate of the global Keyword market over the forecast period?
  • What are the major factors driving the global market revenue growth?
  • Which are the leading manufacturers and suppliers in the global Keyword market?
  • Which regional market is expected to lead in terms of revenue share in the global Keyword market over the forecast years?
  • What are the key outcomes of SWOT analysis and Porter’s Five Forces analysis of the market?

Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.

Read More Reports:

Disposable Blood Pressure Cuffs Market:

Preimplantation Genetic Testing Market:

Cell Culture Protein Surface Coating Market:

Reprocessed Medical Devices Market:

X-Ray Photoelectron Spectroscopy (XPS) Market:

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.


101 Blog posts